News
Latest news and scientific insights from Clonit
![](/repoimg/News/146-card-news-equita.png.jpg)
17 Mag 2022
Equita Smart Capital
Equita Smart Capital – ELTIF, fondo di private equity gestito da Equita Capital SGR,...
Read more![](/repoimg/88-card-Dynamiker%20Fugal%20diseases.jpg)
07 Mar 2022
Partnership with Dynamiker Biotechnology (Tianjin) Co.,Ltd
Clonit is proud to announce the new partnership with Dynamiker Biotechnology (Tianjin) Co.,Ltd as...
Read more![](/repoimg/72-card-logo_amcli.jpg.jpg)
18 Gen 2022
XLIX CONGRESSO NAZIONALE AMCLI
Clonit è lieta di annunciare la propria presenza alla XLIX edizione del Congresso Nazionale...
Read more![](/repoimg/News/73-card-immagine%20omicron.JPG.jpg)
28 Dic 2021
Ultra Variant Catcher Clonit: Identificazione Variante Omicron.
Ultra Variant Catcher Clonit: Identificazione Variante Omicron.
Read more
![](/repoimg/71-card--covid-Varianti.JPG.jpg)
30 Giu 2021
COVID-19 Ultra Variant Catcher kit
Every patients is different and every day is different. Sars Cov 2 Virus is changing and the only...
Read more![](/repoimg/News/70-card-ISC.JPG.jpg)
26 Mag 2021
Covid-19 HT & Saliva
Clonit R&D team has achieved a new landmark with the evaluation of our Covid-19 kit from Saliva...
Read more